Matthew E. Korenberg, President & COO at LIGAND PHARMACEUTICALS INC (LGND), sold 31,893 shares at $100.05 ($3.3M) on 2024-09-23, disclosed to the SEC on 2024-09-24.
Open-market sale of $3.3M LGND by President & COO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $104.10 | 6,275 | $653K | 20.0% |
| 2 | $104.10 | 6,275 | $653K | 20.0% |
| 3 | $100.05 | 2,481 | $248K | 7.6% |
| 4 | $100.05 | 2,481 | $248K | 7.6% |
| 5 | $101.61 | 7,090 | $720K | 22.1% |
| 6 | $101.61 | 7,090 |
| $720K |
| 22.1% |
| 7 | $102.05 | 201 | $21K | 0.6% |
| Total | $102.35 avg | 31,893 | $3.3M | 100% |
| Filing → |
| LGND | SELL | 2024-05-15 | $2.9M | — | Filing → |
| LGND | BUY | 2019-09-03 | $43K | — | Filing → |
| LGND | SELL | 2018-08-29 | $9.4M | — | Filing → |